Lunai Bioworks Inc. LNAI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 98.41% | -1,459.09% | 75.19% | 106.38% | -705.59% |
| Total Depreciation and Amortization | -56.75% | -125.94% | -65.11% | 28.09% | 4.82% |
| Total Amortization of Deferred Charges | -- | -- | 381.93% | -21.94% | -100.00% |
| Total Other Non-Cash Items | -99.89% | 139.18% | -93.00% | -113.02% | 1,197.55% |
| Change in Net Operating Assets | -99.54% | -75.82% | -56.87% | -50.56% | -57.96% |
| Cash from Operations | -1.65% | 30.96% | 58.15% | 33.09% | 24.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 100.00% | -- | -- | 3,336.24% |
| Cash from Investing | -100.00% | 100.00% | -- | -- | 1,905.99% |
| Total Debt Issued | -100.00% | -40.65% | -92.05% | 929.32% | 28.22% |
| Total Debt Repaid | 43.41% | -380.12% | 100.00% | -21.30% | -21.30% |
| Issuance of Common Stock | -- | -100.00% | 167.86% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 121.19% | 3.33% | -63.33% | -33.80% | -92.77% |
| Foreign Exchange rate Adjustments | 102.96% | 38.68% | -117.86% | 46.88% | -76.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.62% | 335.80% | -246.05% | 532,000.00% | -800.54% |